Yuflyma® (Adalimumab), Patient Experience After Switching

NCT05427942 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Ankylosing Spondylarthritis
Axial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis
Psoriatic Arthritis
Crohn Disease
Ulcerative Colitis

Interventions

DRUG: Adalimumab

Sponsor

Celltrion HealthCare France